Spherix Incorporated (SPEX) - NASDAQ
  • Thu, May 26, 12:45 PM
    | Thu, May 26, 12:45 PM
  • Wed, May 25, 12:50 PM
    | Wed, May 25, 12:50 PM
  • Wed, May 25, 9:20 AM
    | Wed, May 25, 9:20 AM
  • Tue, May 24, 2:54 PM
    • Under a second licensing deal with IP risk-management services firm RPX (RPXC), Spherix (SPEX +79.1%) "receives a cash payment and return of all of the Series H preferred stock of Spherix presently held by RPX, representing the entire class of Series H shares outstanding." In return, Spherix is granting RPX a patent portfolio license RPX can sub-license to its clients.
    • With the company having a market cap of less than $6M going into today, Spherix has blasted off on the news.
    | Tue, May 24, 2:54 PM
  • Tue, May 24, 12:50 PM
    | Tue, May 24, 12:50 PM | 7 Comments
  • Tue, May 24, 9:14 AM
    | Tue, May 24, 9:14 AM | 7 Comments
  • Thu, Mar. 10, 12:48 PM
    | Thu, Mar. 10, 12:48 PM
  • Mon, Mar. 7, 12:15 PM
    • "Our goal is to drive long-term shareholder value through partnerships that will initiate litigation across numerous technology sectors, including: routers, switching, networking, optical, and internet service," says Spherix (SPEX +21.4%) CEO Anthony Hayes in a letter, trying to drum up shareholder support. "Multiple litigations, against multiple licensees, in multiple technology fields will help to optimize potential revenue generation."
    • He asserts Spherix can now pursue its strategy, after having recently satisfied preferred stock payment obligations and seen the termination of security interests on its assets. "Prior to the end of 2015, we did not have the right to leverage our portfolio in such a manner."
    • Hayes adds licensing talks continue with IP risk-management services firm RPX, and that his company hopes to reach a deal. "By agreement, these discussions can continue until May 23rd of this year. If an agreement is not reached by May 23rd, then the agreed "stay" on litigation expires and the number of potential licensees to our portfolio increases significantly."
    • The letter comes after Spherix carried out a 1:19 reverse split on Friday.
    | Mon, Mar. 7, 12:15 PM | 1 Comment
  • Dec. 2, 2015, 9:52 AM
    • Spherix (NASDAQ:SPEX) is raising $4M by selling 20M Class A units consisting of one share, a warrant (exercisable for 6 months) to buy one share at a price equal to the unit offering price, and a warrant (exercisable for 5 years) to buy 0.8 shares at a price equal to 125% of the unit offering price.
    • Spherix is also issuing Class B units to those investors whose purchase of A units would lead them to own more than a 4.99% stake in the company following the offering. Each B unit consists of one Class K convertible preferred share, which in turn is convertible into common stock at the A unit offering price.
    • Shares have plunged below $0.19; the 52-week low is $0.17. Ahead of today's announcement, Spherix tried to drum up investor enthusiasm by issuing a PR detailing potential licensing opportunities.
    | Dec. 2, 2015, 9:52 AM
  • Oct. 19, 2015, 10:06 AM
    • Spherix (NASDAQ:SPEX) and Chinese IT/telecom equipment Huawei have settled all litigation, with the latter obtaining a patent license from the former. At the joint request of both companies, the USPTO has terminated inter partes reviews involving two Spherix patents.
    • Spherix jumped in August on news it has signed an MOU with Huawei that "favorably resolves" Spherix's suit. Shares still -38% YTD.
    | Oct. 19, 2015, 10:06 AM
  • Aug. 24, 2015, 2:28 PM
    • Spherix (NASDAQ:SPEX) has signed an MOU with Huawei that "favorably resolves" an infringement suit against the Chinese tech giant. Management expects "all documents necessary to resolve this matter will be executed in the next 30 days." Terms are undisclosed.
    • Shares have soared in afternoon trading, after initially seeing more modest gains. They're still down 62% YTD.
    | Aug. 24, 2015, 2:28 PM | 7 Comments
  • Jul. 16, 2015, 9:53 AM
    • Spherix (NASDAQ:SPEX) has reached agreements with institutional investors to sell 5.72M units consisting of one share and a warrant to buy 1.23 shares. The warrants will carry a $0.43 exercise price, be exercisable six months and one day after the closing of the offering, and expire 5.5 years after the offering's close.
    • Gross proceeds are expected to total $1.5M, excluding any warrant exercises - that implies each unit will be sold for ~$0.26. Spherix had $2.9M in cash at the end of Q1, and currently has 28.6M shares outstanding.
    | Jul. 16, 2015, 9:53 AM
  • Mar. 31, 2015, 1:17 PM
    • Spherix (NASDAQ:SPEX) filed its 2014 10-K after the close yesterday afternoon.
    • Shares are down 12% over the last two days. Yesterday morning, Spherix announced the trial date for its suit against Verizon had been pushed back from May 18 to August 10.
    • Spherix soared 11 days ago after receiving a favorable claim construction order for its suits against VTech and Uniden.
    | Mar. 31, 2015, 1:17 PM | 3 Comments
  • Mar. 20, 2015, 9:31 AM
    • The Northern Texas district judge presiding over Spherix's (NASDAQ:SPEX) cordless phone patent infringement suits against VTech and Uniden has issued a 106-page claim construction order covering 13 claims in dispute.
    • Spherix declares it's pleased with the order, which follows a November Markman hearing. "We are impressed by the depth of the Court's reasoning and we are satisfied with the results on the merits."
    • Among other things, the court rejected VTech/Uniden's arguments for invalidating Spherix's '599 patent for indefiniteness, and also their construction of a limitation within the patent. Their construction of terms within Spherix's '899 and '614 patents were also rejected.
    • In addition, Spherix thinks the order "casts doubt on the merits of Defendants' pending [inter partes review] Petitions" with the USPTO (previous). "The Patent Trial and Appeal Board instituted the IPRs without having the benefit of Spherix's expert testimony and without seeing the cross-examination of the Defendants' experts on the statements made in their IPR declarations. We believe the Court's claim construction order casts substantial doubt on the credibility of these experts..."
    • Shares have soared towards $1.00 on the news. They had fallen sharply in recent weeks.
    | Mar. 20, 2015, 9:31 AM | 1 Comment
  • Mar. 13, 2015, 9:19 AM
    • Spherix (NASDAQ:SPEX) states the USPTO has granted VTech and Uniden's request for an inter partes review of a portion of the claims in two Spherix patents being asserted against the companies.
    • The company notes the review doesn't "apply broadly to all claims under these patents nor to all of the Company's other claims of infringement asserted against VTech and Uniden," and that it isn't "related to the patents involved in the litigations brought against Cisco, Verizon, Juniper, Huawei or T- Mobile."
    • Shares have risen to $0.95 premarket. They tumbled yesterday, but wound up recovering about half their intraday losses by the close. A closely-watched Markman hearing for Spherix's suit against Verizon takes place on Monday.
    | Mar. 13, 2015, 9:19 AM
  • Mar. 12, 2015, 1:04 PM
    • Spherix (NASDAQ:SPEX) has tumbled to 52-week lows on volume (1.41M shares) that's over 5x a 3-month daily average of 267K.
    • The plunge comes ahead of a Monday Markman hearing for Spherix's infringement suit against Verizon. Spherix has accused Verizon's Internet services of infringing ex-Nortel patents obtained through its deal with the Rockstar consortium.
    • Previously: Spherix rises after providing litigation update
    | Mar. 12, 2015, 1:04 PM | 2 Comments
Company Description
Spherix, Inc. operates as an intellectual property company that owns patented and unpatented intellectual property. Its principal activities include the acquisition and development of patents through internal or external research and development. In addition, the company intends to acquire... More
Sector: Healthcare
Industry: Medical Laboratories & Research
Country: United States